Bioactivity of growth hormone releasing hormone (1–29) analogues after SC injection in man
- 27 January 1989
- Vol. 10 (1) , 1-4
- https://doi.org/10.1016/0196-9781(89)90065-x
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- An evaluation of intravenous, subcutaneous, and in vitro activity of new agmatine analogs of growth hormone-releasing hormone hGH-RH(1–29)NH2Life Sciences, 1988
- Rapid enzymatic degradation of growth hormone-releasing hormone by plasma in vitro and in vivo to a biologically inactive product cleaved at the NH2 terminus.Journal of Clinical Investigation, 1986
- Effects of Intravenous, Subcutaneous, and Intranasal Administration of Growth Hormone (GH)-Releasing Hormone-40 on Serum GH Concentrations in Normal Men*Journal of Clinical Endocrinology & Metabolism, 1985
- Growth hormone responses to growth hormone-releasing hormine (1–29)-NH2 and a D-Ala2 analog in normal menPeptides, 1985
- Structure-activity studies on the N-terminal region of growth hormone releasing factorJournal of Medicinal Chemistry, 1985
- An Extremely Sensitivein VitroModel for Elucidating Structure-Activity Relationships of Growth Hormone-Releasing Factor Analogs*Endocrinology, 1985
- RESPONSES TO ANALOGUES OF GROWTH HORMONE-RELEASING HORMONE IN NORMAL SUBJECTS, AND IN GROWTH-HORMONE DEFICIENT CHILDREN AND YOUNG ADULTSClinical Endocrinology, 1984
- Growth hormone releasing factor: comparison of two analogues and demonstration of hypothalamic defect in growth hormone release after radiotherapy.BMJ, 1984
- Super-active analogs of growth hormone-releasing factor (1–29)-amideBiochemical and Biophysical Research Communications, 1984
- Growth Hormone-Releasing Factor from a Human Pancreatic Tumor That Caused AcromegalyScience, 1982